Skip to Main Content

Seeing the Easter Bunny wear a mask was weird. Greetings and welcome to another semi-regular column on the Covid-19 pandemic. In this edition: When will biotech M&A return? Did Sage Therapeutics CEO take a pay cut? Biotech in an America First world; and more chatter about #JPM21.

What will it take for mergers and acquisitions to return to biotech?


Last week’s Roche-Arrakis Therapeutics partnership was proof that deal-making can get done via video chats. It helped that those companies — one very large, one very small — started speaking to each other last year when face-to-face business meetings were still a thing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!